Alabama Needs More Vaccines To Stop The Spread Of COVID-19, Doctor Says

 1520489193 
1612265449
UAB

Dr. Jeanne Marrazzo, director of UAB’s Division of Infectious Diseases, receives the hospital’s first dose of the Pfizer COVID-19 vaccine on Dec. 18.

To combat COVID-19, the virus variants that are now spreading in the U.S. and the high infection rate in Alabama, the state needs more vaccines, the head of UAB’s Infectious Disease Division said Tuesday.

“People need to get that first shot before new variants of the virus take hold,” Dr. Jeanne Marrazzo said during a press conference.

Alabama still leads the nation with a positivity rate of 33.4%, as reported Tuesday by the Johns Hopkins Coronavirus Resource Center. That means that, of everyone tested for the coronavirus, more than a third of them have it.

The state has gotten 800,000 vaccine doses and delivered 374,000, which “translates to 1.1% of our entire population,” Marrazzo said. “I don’t think those numbers are great. Hopefully, that is attributed to a delay in reporting.”

Marrazzo pointed to states that have distributed a high percentage of their vaccines, such as Alaska, with 63% of its vaccines distributed; South Dakota, with 75%; and North Dakota, with 81%.

“A lot of it has to do with the organizational capacity of the public health service, she said.

The number of hospitalizations for COVID treatment in Alabama had dropped to 1,888 patients Monday from a peak of 3,000 earlier this year. That trend is also reflected at UAB Hospital. But Marrazzo said the number of deaths and positivity rates in the state has not budged.

She said 60% to 70% of Alabamians would need to be immunized to reach the level she thinks the state should be at.

“That will take a couple of years, and no one wants to hear that. We need to ramp up the rate,” she said.

That would also provide immunizations to the most vulnerable populations.

Marrazzo said the United Kingdom COVID-19 variant is better at attaching itself to the linings of the nose and throat, and it is more infectious.

On the good news side, she said the Johnson & Johnson trial vaccine is a single dose with a 72% efficacy rate. But, she said, “It is especially good at preventing serious disease requiring hospitalization and intubation,” and it is a major advance.

The status of COVID-19 across the country is “relatively stable to improving,” with 150,000 new cases daily compared to 250,000 cases in mid-January.

But, she added, what is not down is the number of deaths. Three thousand people are dying from the virus each day.

“We are very hopeful that in the coming weeks, we will see those numbers decline as well,” she said.

Editor’s Note: This story from BirminghamWatch has been corrected to refer to the high percentage of vaccines received that Alaska, North Dakota and South Dakota have been able to get to their residents, not the percentage of people who have been vaccinated.

UAB holds WBHM’s broadcast license, but our news and business departments operate independently.

More Coronavirus Coverage

ADPH Plans Mobile Vaccination Clinics For Black Belt Region

State health officials hope to administer more vaccines to residents of rural areas.

Ivey Extends Face Mask Order But Not For Long

Gov. Ivey leaves face mask order alone for now, but says it will end April 9.

UAB And JeffCo To Expand Vaccine Outreach In Underrepresented Communities

As of Wednesday, UAB had administered roughly 80,000 vaccine doses, but Black residents remain disproportionately underrepresented.

Birmingham Divvies Up $500K In Bold Funding For Nonprofits

Nine Birmingham nonprofits will receive funding from the city’s Building Opportunities for Lasting Development grant initiative this year, despite an overall reduction in funding for the program.

Alabama’s COVID-19 Death Count Nears 10,000 Mark

Within about a year, the state has lost almost 10,000 Alabamians to COVID-19.

UAB Officials Hopeful Johnson & Johnson Vaccine Could Accelerate Rollout

UAB health experts say when it comes to vaccine variety, more is better. The Johnson & Johnson vaccine is the latest to win approval from the federal government.

More Coronavirus Coverage